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Individual cell heterogeneity within a population can be critical to its peculiar function
and fate. Subpopulations studies with mixed mutants and wild types may not be as
informative regarding which cell responds to which drugs or clinical treatments. Cell
to cell differences in RNA transcripts and protein expression can be key to answering
questions in cancer, neurobiology, stem cell biology, immunology, and developmental
biology. Conventional cell-based assays mainly analyze the average responses from a
population of cells, without regarding individual cell phenotypes. To better understand
the variations from cell to cell, scientists need to use single cell analyses to provide
more detailed information for therapeutic decision making in precision medicine. In this
review, we focus on the recent developments in single cell isolation and analysis, which
include technologies, analyses and main applications. Here, we summarize the historical
background, limitations, applications, and potential of single cell isolation technologies.
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INTRODUCTION
The cell is the fundamental unit of biological organisms. Despite the apparent synchrony in cellular
systems, analyzed single cell results show that even the same cell line or tissue, can present different
genomes, transcriptomes, and epigenomes during cell division and differentiation (Schatz and
Swanson, 2011). For example, a developing embryo, brain, or tumor have intricate structures
consisting of numerous types of cells that may be spatially separated. Thus, the isolation of distinct
cell types is essential for further analysis and will be valuable for diagnostics, biotechnological and
biomedical applications.
Conventional cell-based assays mainly measure the average response from a population of cells,
assuming the average response is representative of each cell. However, in doing this important
information about a small but potentially relevant subpopulation maybe lost, particularly in cases
where that subpopulation determines the behavior of the whole population. For example, the
tumor microenvironment is a complex heterogeneous system that consists of multiple intricate
interactions between tumor cells and its neighboring non-cancerous stromal cells. The stromal
cells are composed of endothelial cells, fibroblasts, macrophages, immune cells, and stem cells.
Due to the variation in genetic and environmental factors, different kinds of cells have unique
behaviors and present different implications in pathogenic conditions (Schor and Schor, 2001).
These challenges make conventional analysis insufficient. Therefore, new technologies to isolate
individual single cells from a complex sample and study the genomes and proteomes of single cells
could provide great insights on genome variation and gene expression processes. It is believed that
single cell analyses have influences on various fields including life sciences and biomedical research
(Blainey and Quake, 2014).
Hu et al. Single Cell Isolation and Analysis
In early times, researchers have applied low-throughput
single cell analysis techniques, such as immunofluorescence,
fluorescence in situ hybridization (FISH) and single cell PCR, to
detect certain molecular markers of single cells (Taniguchi et al.,
2009; Citri et al., 2012). These techniques allow quantification
of a limited number of parameters in single cells. On the other
hand, high-throughput genomic analysis, such as DNA and RNA
sequencing are now widely used. However, genomic studies rely
on studying collective averages obtained from pooling thousands
to millions of cells, precluding genome-wide analysis of cell
to cell variability. Therefore, single cell sequencing developed
alongside its necessity in research awarding it “method of the
year” by Nature Methods in 2013 (2014). By using single cell
analysis, researchers have profiled many biological processes
and diseases at the single cell level including tumor evolution,
circulating tumor cells (CTCs), neuron heterogeneity, early
embryo development, and uncultivatable bacteria.
In this review, we discuss the technologies recently developed
for single cell isolation, genome acquisition, transcriptome, and
proteome analyses, and their applications. We also briefly discuss
the future potentials of single cell isolation technologies and
analyses.
TECHNOLOGIES FOR SINGLE CELL
ISOLATION
Before initiating a single cell analysis, scientists need to isolate or
identify single cells. The performance of cell isolation technology
is typically characterized by three parameters: efficiency or
throughput (how many cells can be isolated in a certain
time), purity (the fraction of the target cells collected after the
separation), and recovery (the fraction of the target cells obtained
after the separation as compared to initially available target cells
in the sample). The current techniques show different advantages
for each of the three parameters.
Based on the variety of principles used, current existing
cell isolation techniques can be classified into two groups.
The first group is based on physical properties like size,
density, electric changes, and deformability, with methods
including density gradient centrifugation, membrane filtration
and microchip-based capture platforms. The most advantageous
physical properties is single cell isolation without labeling. The
second group is based on cellular biological characteristics,
comprising of affinity methods, such as affinity solid matrix
(beads, plates, fibers), fluorescence-activated cell sorting, and
magnetic-activated cell sorting, which are based upon biological
protein expression properties (Dainiak et al., 2007). Thus, in
what follows we briefly summarize the principle of each method,
as well as the advantage and limitation of their applications
(Table 1). We will not discuss limiting dilution since it is well
known in the field of monoclonal cell cultures production.
Fluorescence Activated Cell Sorting (FACS)
Fluorescence Activated Cell Sorting (FACS), a specialized type of
flow cytometry with sorting capacity, is the most sophisticated
and user-friendly technique for characterizing and defining
different cell types in a heterogeneous cell population based on
size, granularity, and fluorescence. FACS allows simultaneous
quantitative and qualitative multi-parametric analyses of single
cells (Gross et al., 2015). Before separation, a cell suspension is
made and the target cells are labeled with fluorescent probes.
Fluorophore-conjugated monoclonal antibodies are the most
widely used fluorescent probes (mAb) that recognize specific
surface markers on target cells. As the cell suspension runs
through the cytometry, each cell is exposed to a laser, which
allows the fluorescence detectors to identify cells based on the
selected characteristics. The instrument applies a charge (positive
or negative) to the droplet containing a cell of interest and
an electrostatic deflection system facilitates the collection of
the charged droplets into appropriate collection tubes for later
analysis (Figure 1A). Although FACS has been widely used for
isolation of highly purified cell populations, it has been reported
that FACS can also be used to sort single cells (Schulz et al., 2012).
For example, BD cell sorting systems (such as the BD FACSAria
III Cell Sorter) are able to isolate single cells of interest from
thousands of cells in a population using up to 18 surface markers.
Since the late 1960s, remarkable advances have been made
on the FACS technology including the instrumentation and the
availability of a large number of highly specific antibodies. The
capability of FACS technology has improved significantly from
a technique limited to measuring 1–2 fluorescent species per
cell to 10–15 species. The maximum number of proteins that
can be simultaneously measured has progressively increased (Wu
and Singh, 2012). Due to this progress, our understanding of
immunology and stem cell biology has improved tremendously
alongside the discovery of scores of functionally diverse cell
populations (Bendall et al., 2012). It has also been reported that
using the next generation cytometry, “post-fluorescence” single
cell technology termed mass cytometry is theoretically capable of
measuring 70–100 parameters.
Although FACS has been widely used in both basic and clinical
research, there are several limiting disadvantages. First, FACS
requires a huge starting number of cells (more than 10,000) in
suspension. Therefore, it fails to isolate single cells from a low
quantity cell population. Second, the rapid flow in the machine
and non-specific fluorescent molecules can damage the viability
of the sorted cells rendering the isolation a failure. Moreover, cells
or cell cultures must be subjected to stimulation experiments and
treated in a separate environment before FACS analysis.
Magnetic-Activated Cell Sorting (MACS)
Magnetic-Activated Cell Sorting (MACS) is another commonly
used passive separation technique to isolate different types of cells
depending on their cluster of differentiation. It has been reported
that MACS is capable of isolating specific cell populations with a
purity >90% purification (Miltenyi et al., 1990). MACS is based
on antibodies, enzymes, lectins, or strepavidins conjugated to
magnetic beads to bind specific proteins on the target cells. When
a mixed population of cells is placed in an external magnetic
field, the magnetic beads will activate and the labeled cells will
polarize while other cells are washed out. The remaining cells
can be acquired by elution after the magnetic field is turned off
(Figure 1B). With this technique, the cells can be separated by
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TABLE 1 | Overview of single cell isolation techniques.
Techniques Throughput Advantage Disadvantage References
Fluorescence-activated cell sorting (FACS) High High specificity multiple parameters Large amount of material,
dissociated cells, high skill needed
Gross et al., 2015
Magnetic-activated cell sorting (MACS) High High specificity, cost effective Dissociated cells, non-specific cell
capture
Welzel et al., 2015
Laser capture microdissection (LCM) Low Intact fixed and live tissue Contaminated by neighboring cells,
high skill needed
Espina et al., 2007;
Datta et al., 2015
Manual cell picking Low Intact live tissue High skill needed, low throughput Citri et al., 2012
Microfluidic High Low sample consumption,
integrated with amplification
Dissociated cells, high skill needed Bhagat et al., 2010;
Lecault et al., 2012
FIGURE 1 | Overview of single-cell isolation technologies discussed in the section. (A) Schematic of fluorescence-activated cell sorting. The suspended
labeled cells are passed as a stream in droplets with each containing a single cell in front of a laser. The fluorescence detection system detects the fluorescent and light
scatter characteristics. Based on their characteristics, the instrument applies a charge to the droplet containing a cell of interest and an electrostatic deflection system
facilitates collection of the charged droplets into different collecting tubes. Cells labeled with green, purple, and yellow indicate different cell types. (B) Schematic of
magnetic-activated cell sorting. Cells of interest are labeled with specific antibody conjugated magnetic beads. An external magnetic field is used to separate the
labeled cells from the cell suspension. S and N indicate magnetic field. (C) Schematic of laser capture microdissection. The technique utilizes a laser which fired
through the cap over the cells of interest to melt the membrane to let the cells adhere to the melted membrane. When the cap is removed, captured cells are removed,
leaving the unwanted cells behind. (D) Schematic of manual cell picking. The cells of interest are monitored under a microscope. By using a glass pipette connected
to a micromanipulator, single cells can be collected and transferred to a new tube for following analysis. (E) Schematic of microfluidic used for single cell isolation.
Before starting the experiments, cells need to be dissociated then flow into a chip. Thus, the cells may be separated into different tubes containing only one cell.
charge with respect to the particular antigens. Positive separation
techniques use coated magnetic beads and attract cells. The cells
of interest are labeled while the unlabeled cells are discarded.
In contrast, if species-specific substances are unavailable, a good
choice is to use negative separation techniques which employ a
cocktail of antibodies to coat untreated cells. In this case, labeled
cells are discarded while unlabeled are retained (Grützkau and
Radbruch, 2010).
Of the two most common affinity-based techniques for
specific cell isolation, MACS technology is comparatively
simple and cost-effective. However, the MACS system’s obvious
shortcoming lies in its initial costs in the separation magnet,
and running costs including not only the price of the conjugated
magnetic beads, but also replacement columns. In addition, the
final purity of isolated cells in MACS devices depends on the
specificity and the affinity of the antibodies used to select the
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target cells. It also depends on the amount of non-specific cell
capture. Non-specific contamination can be from adsorption of
background cells to the capturing device or their entrapment
within the large excess of magnetic particles needed for labeling
rare cells in large volumes. Using new materials can eliminate
contamination from non-specific adsorption or entrapment of
other blood cells. Another disadvantage of MACS is that it can
only utilize cell surface molecules as markers for separation of
live cells. Furthermore, it should be noted that MACS is far more
limited than FACS because of immunomagnetic techniques that
can only separate cells into positive and negative populations.
High and low expression of a molecule cannot be separated while
it is possible by using FACS sorting.
Laser Capture Microdissection (LCM)
Laser Capture Microdissection (LCM) is an advanced technology
for isolating pure cell populations or a single cell from
mostly solid tissue samples on a microscope slide (Emmert-
Buck et al., 1996). It can accurately and efficiently target
and capture the cells of interest to fully exploit emerging
molecular analytical technologies, including PCR, microarrays
and proteomics (Espina et al., 2007). Today, there are two general
classes of laser capture microdissection systems: infrared (IR
LCM) and ultraviolet (UV LCM). The LCM system consists of
an inverted microscope, a solid state near infrared laser diode,
a laser control unit, a joy stick controlled microscope stage with
a vacuum chuck for slide immobilization, a CCD camera, and a
color monitor (Datta et al., 2015). The basic principle of LCM
starts with visualizing the cells of interest through an inverted
microscope, then a fixed-position, short duration and focused
laser pulse is delivered to melt the thin transparent thermoplastic
film on a cap above the targeted cells. The film melts and fuses
with the underlying cells of choice. When the film is removed,
the target cells remain bound to the film while the rest of the
tissue is left behind. Finally, transfer the cells to a microcentrifuge
tube containing buffer solutions required for a wide range of
downstream analysis (Kummari et al., 2015; Figure 1C).
The most important advantage of LCM is its speed
while maintaining precision and versatility (Fend and Raffeld,
2000). LCM provides a rapid, reliable method to procure
pure populations of target cells from a wide range of
cell and tissue preparations via microscopic visualization
(Bonner et al., 1997). Conventional techniques for molecular
analysis require dissociation of tissue. This may introduce
inherent contamination problems and reduce the specificity and
sensitivity to subsequent molecular analysis. On the other hand,
LCM is a “no touch” technique that does not destroy adjacent
tissues after initial microdissection. Morphology of both the
captured cells as well as the residual tissue is well preserved and
reduces the danger of tissue loss (Esposito, 2007). In addition,
after removing the chosen cells, the remaining tissue on the
slide is fully accessible for further capture, allowing comparative
molecular analysis of adjacent cells.
The major requirement for effective LCM is correct
identification of cell subpopulations or single cells in a complex
tissue. Thus, the major limitation is the need to identify cells of
interest through visual microscopic inspection of morphological
characteristics, which in turn, requires a pathologist, cytologist,
or technologist trained in cell identification (Espina et al., 2007).
Another significant limitation is that the microdissected tissue
section does not have a cover slip. Cover slipping would prevent
physical access to the tissue surface, which is crucial to any
current microdissection method. Without a cover slip, and the
index matching between the mounting media and the tissue, the
dry tissue section has a refractile quality, which might obscure
cellular detail at high magnifications. Moreover, LCM introduces
a number of technical artifacts, including slicing the cells during
the preparation of tissue sections and UV damage to DNA or
RNA from the laser cutting energy (Allard et al., 2004).
Manual Cell Picking/Micromanipulation
Manual cell picking is a simple, convenient, and efficient
method for isolating single cells. Similar to LCM, manual
cell picking micromanipulators also consists of an inverted
microscope combined with micro-pipettes that are movable
through motorized mechanical stages. Each isolated single cell
can be observed and photographed under the microscope,
thus enabling unbiased isolation (Figure 1D). Unlike LCM
that mainly isolates single cells from sections of fixed tissue,
micromanipulation plays an important role in isolating live
culture cells or embryo cells.
Micromanipulation can be easily performed in an
electrophysiology lab equipped with a patch clamp system.
For example, after investigating neuronal function in brain
slices preparations after standard whole-cell patch-clamp
electrophysiological recordings, scientists would apply negative
pressure through the patch pipette so that the cytosolic material
containing cellular mRNA can be aspirated for further analysis
(Eberwine et al., 1992; Citri et al., 2012). However, the throughput
is limited and it requires highly skilled professionals to perform,
it has the utility limitation when detecting complex changes.
Microfluidics
Microfluidics is recognized as a powerful enabling technology
for investigating the inherent complexity of cellular systems
as it provides precise fluid control, low sample consumption,
device miniaturization, low analysis cost, and easy handling of
nanoliters-volumes (Whitesides, 2006; Figure 1E). Cell Sorting
by a microfluidic chip can be divided into four categories:
cell-affinity chromatography based microfluidic (Nagrath et al.,
2007), physical characteristics of cell based microfluidic
separation, immunomagnetic beads based microfluidic
separation, and separation methods based on differences
between dielectric properties of various cell types.
Cell-affinity chromatography based microfluidic is the most
commonly used method for microfluidic chip analysis. It is based
upon highly specific interactions between antigen and antibody,
ligand and receptor. At the beginning of the process, the micro-
channel in the chip is modified with specific antibodies capable
of binding to cell surface antigen or aptamer, such as an epithelial
cell adhesion molecule. Once the sample flows through the
micro-channels, its cell surface antigen can bind to the specific
antibodies or aptamer immobilizing the cells on the chip, while
the remaining cells flow off the chip with the buffer. Finally,
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using a different buffer, we can elute the immobilized cells for
downstream analysis. Compared to other separation methods,
affinity based systems have higher specificity and sensitivity
because of the recognition-binding event.
Today, microfluidics can be combined with different
separation methods, such as filtration and sedimentation
or affinity-based technologies like FACS and MACS. In the
recent years, numerous investigations and applications in
microfluidic devices have been reported, including cancer
research, microbiology, single-cell analysis, stem cell research,
drug discovery, and screening (Arora et al., 2010; Li et al., 2012a).
Recently, microfluidic chips have been fabricated from silicon
or glass, elastomer, thermosets, hydrogel, thermoplastics, and
paper (Ren et al., 2013, 2014). The advantages and disadvantages
of the materials used in microfluidic chips have been well-
summarized previously (Ren et al., 2014). Microfluidics are
used to manipulate liquids (dimensions from 1 to 1000µm) in
networks of micro-channels in a single device. At such ultralow
volumes, fluids exhibit different physico-chemical properties
compared to their behavior at the macro-scale (Squires and
Quake, 2005). Other common fluids can be used in microfluidic
devices include bacterial cell suspensions, whole blood samples,
protein or antibody solutions, and various buffers.
Taking advantages of integrating cell handling and processing
concurrently, microfluidic chips show potential applications in
DNA sequencing (Hashimoto et al., 2007; Liu et al., 2007),
protein analysis (Emrich et al., 2007), cell manipulation, and cell
composition analysis (VanDijken et al., 2007; Bhagat et al., 2010).
For example, Fluidigm developed a commercially available valve-
based microfluidic qPCR system called the Dynamic ArrayTM.
This system advanced on providing low-volume (nanoliter)
and high-throughput (thousands of PCR reactions per device)
methods to the researchers and has become increasingly
popular for large-scale single cell studies. Moreover, microfluidic
technology has shown increasing applications in studying
diversity and variations in single cell genomes, spanning from
cancer biology to environmental microbiology and neurobiology.
Beyond genomics applications, the scalability and small volume
advantages of microfluidic methods have found applications in
the measurement of intracellular and secreted proteins from
single cells.
SINGLE CELL ANALYSIS
Single cell analysis tools can be divided into three groups:
genomics, transcriptomics, and proteomics. Due to next
generation sequencing (NGS) technologies as well as whole
genome/transcriptome amplification (WGA/WTA) approaches,
a new scientific field of single cell genome studies have
been established. A combination of high-throughput and
multiparameter approaches is used in single cell analysis which
can reflect cell to cell variability and heterogeneous differences
in the individual cells. Therefore, the development of efficient
single cell analysis methods requires attention. In this section,
we discuss novel technologies designed for single cell analysis of
genomics, transcriptomics, and proteomics (Table 2).
Single Cell Genomics
Single cell genome sequencing allows us to identify chromosomal
variations, such as copy number and single-nucleotide variations.
It also allows us to study tumor evolution, gamete genesis,
and somatic mosaicism, which is reflected in the genomic
heterogeneity among a population of cells. However, in humans,
it often faces the low amount of genome materials, for example,
the weight of one genomic DNA is only 6 pg and each gene
in the genome only has two copies in a single normal cell
which is not quite enough for the current NGS use. However,
amplification using traditional PCR suffers from severe biases
and allelic dropout across the genome when it is applied to
single cells. Therefore, a precise, unbiased amplification of
the DNA is critical to single cell genome sequencing. Lots
of attempts were made, mostly by modifying the traditional
PCR methodology to linker-adapter PCR (LA-PCR) (Klein
et al., 1999), interspersed repetitive sequence PCR (IRS-PCR),
primer extension pre-amplification PCR (PEP-PCR) (Hubert
et al., 1992), degenerate oligonucleotide-primed PCR (DOP-
PCR) (Telenius et al., 1992), and its variant displacement
DOP-PCR (D-DOP-PCR) (Langmore, 2002). For example, by
using DOP-PCR, Navin and colleagues demonstrated accurate
and robust determination of genome wide copy number in
rearranged cancer genomes (Navin et al., 2011). This is the first
report of single cell genome sequencing applied to a cancer
genomic heterogeneity study. However, these methods also have
some limitations in low coverage, amplification bias, and allele
dropout.
The multiple displacement amplification (MDA) is the most
popular method applied in genome analysis due to its high
fidelity and simplicity. It can amplify DNA in a 30◦C isothermal
reaction with random hexamer primers and phi29 DNA
polymerase. The kernel of MDA is that phi29 DNA polymerase
can extend the primers with high fidelity and strong processivity,
which exhibits powerful strand displacement ability during the
new strand synthesis (Dean et al., 2002). The displacement
process generates single stranded DNA templates, which are
reprimed and extended, thereby amplifying the DNA in an
isothermal reaction. Based on MDA, Xu and colleagues provided
the first intratumoral genetic landscape at a single-cell level
and demonstrated that clear cell renal cell carcinoma (ccRCC,
the most common kidney cancer) may be more genetically
complex than previously thought (Xu et al., 2012). However,
MDA also suffers from strong biases and high allelic dropout rate
across the genome, making the reaction vulnerable to generating
“chimeras,” resulting in unwanted noise and false results.
Another new method, multiple annealing and looping-based
amplification cycles (MALBAC) showed faithful copy number
variation detection (Zong et al., 2012), which can amplify the
genome of a single cell with high uniformity. MALBAC is
based upon strand displacement pre-amplification that generates
amplicons with complementary ends. Thus, the full amplicons
generated in the reaction seal themselves to form loops to prevent
them from being amplified again. This also ensures that each new
amplicon is replicated from the original templates. Therefore,
the obvious advantage of MALBAC is that it can reduce the
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TABLE 2 | Techniques for single cell analyses.
Methods Classification Throughput Advantage Disadvantage References
Genome PCR* LA-PCR*, IRS-PCR*,
PEP-PCR*, DOP-PCR*
High High coverage Uneven coverage,
amplification bias, allele
dropout
Klein et al., 1999
MDA* None High Homogeneous
coverage
Amplification bias, allele
dropout, “chimera” structure
Spits et al., 2006
MALBAC* None High Homogeneous
coverage
Amplification bias, allele
dropout
Lu et al., 2012: Van
Loo and Voet, 2014
Transcriptome PCR-based amplification RNA-seq, TPEA*, SMART* High Amplify quickly Distort the difference Pan, 2014
IVT* CEL-seq Quartz-seq High Specificity, ratio
fidelity
Low efficiency Hebenstreit, 2012;
Liu et al., 2014
Phi29 DNA polymerase TTA* PMA* High High efficient,
low bias
RNA need to be selected
from the gDNA
Pan et al., 2013; Liu
et al., 2014
Protein Flow cytometry None High More species Spectral overlap Haselgrübler et al.,
2014
Microfluidic flow cytometry None High Small number of
cells
Dissociated cells, high skill
needed
Wu and Singh, 2012
Mass spectrometry LDI-MS*, SIMS*
(MALDI)-MS*
High Low sensitivity No molecular labels,
Femtomolar sensitivity
Haselgrübler et al.,
2014; Liu et al., 2014
*PCR, Polymerase chain reaction; *LA-PCR, linker-adapter PCR; *IRS-PCR, Interspersed repetitive sequence PCR; *PEP-PCR, Primer extension pre-amplification PCR; *DOP-PCR,
degenerate oligonucleotide-primed PCR; *MDA, Multiple displacement amplification; MALBAC, Multiple annealing and looping-based amplification cycles; *TPEA, 3′-end amplification;
*SMART, strand-switch-mediated reverse transcription amplification; *IVT, in vitro transcription; TTA, Total transcript amplification; *PMA, Phi29 mRNA amplification; LDI-MS, Laser
desorption and ionization mass spectrometry; *SIMS, Secondary ion mass spectrometry; *MALDI-MS, Matrix-assisted laser desorption/ionization mass spectrometry.
amplification errors and biases as the starting materials of the
exponential amplification are amplicon separately copied from
the original template. However, it is still needed to improve the
fidelity and lower the bias (Marcy et al., 2007; Wu et al., 2014).
Single Cell Transcriptomics
Single cell transcriptome sequencing has recently emerged as a
powerful technology for revealing differential gene expression
and diverse RNA splicing patterns during early embryonic
development, differentiation and reprogramming. The main
application of single-cell transcriptomics is to connect a cell’s
genotype to phenotype. It is able to detect thousands of
transcripts in various kinds of tissues and cells (Cloonan et al.,
2008; Mortazavi et al., 2008). Although mRNA is not as rare as
DNA in a single cell, there are still thousands of copies. This
is ideal since NGS transcriptome sequencing also requires a
large amount of RNA as the starting material. The mRNA from
single cells needs to be reverse-transcribed to cDNA followed by
cycles of PCR amplification (Sandberg, 2014). The key process in
completing single cell mRNA amplification successfully is based
on performing reverse transcription to double-strand DNA with
high efficiency and low biases.
PCR-based amplification was first reported in single-cell
transcriptome analysis of the preparation of single-cell cDNAs
using cDNAmicroarray and RNA-seq analysis (Brady and Iscove,
1993). The disadvantage of a microarray is the low detection
sensitivity that would likely miss many low-level but key
transcripts. Compared to microarray analysis, RNA-seq analysis
expanded the spectrum of detected genes with high accuracy
and effectively increased the proportion of full-length cDNA.
One advantage of PCR-basedmRNA transcriptome amplification
bias is that it makes the expression difference more visible
between samples and any RNA starting amount can be employed.
But on the other hand, it may distort the original difference
when it is marginal. Several modified PCR-based methods of
cDNA amplification have been developed, such as global PCR
amplification (GA), 3′-end amplification (TPEA), and strand-
switch-mediated reverse transcription amplification (SMART)
(Pan, 2014).
In vitro transcription (IVT)-based amplification linear RNA
amplification is the first strategy that has been used to successfully
amplify RNA for molecular profiling studies, which promoted
the birth of the era of single cell analysis (Liu et al., 2014). It is
based on T7 RNA polymerase-mediated IVT and requires three
rounds of amplification. The main advantages of the IVT strategy
include its specificity, ratio fidelity, and reducing accumulation
non-specific products, but has the drawback of low efficiency and
a time consuming procedure.
Recently, single cell RNA amplification methods have been
raised based on the Phi29 DNA polymerase (Blanco and Salas,
1984; Dean et al., 2002). This polymerase is a highly processive
enzyme with strong strand displacement activity that allows for
highly efficient isothermal DNA. The phi29 DNA polymerase-
based transcriptome amplification method is a simple, fast and
isothermal reaction (Liu et al., 2014). The primary advantage of
this method is the highly efficient, low bias, and uniform nature
of amplification.
Furthermore, in order to retain the spatial and temporal
information of RNAs in cells, several new RNA sequencing
methods have been developed, including transcriptome in vivo
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analysis (TIVA), single molecule fluorescent in situ hybridization
(smFISH), fluorescent in situ RNA sequencing (FISSEQ), and
so on (Lee et al., 2014; Lovatt et al., 2014). These technologies
become powerful tools for unraveling longstanding biomedical
questions.
Single Cell Proteomics
Single cell analysis of DNA and RNA can provide qualitative
information about protein expression. However, they cannot
give information on protein concentration, location, post-
translational modifications, or interactions with other proteins.
Thus, single-cell proteomics help us obtain much more
information that is crucial in cell signaling and cell to cell
heterogeneity. Traditional protein analysis techniques, such as
gel electrophoresis, immunoassays, chromatography, and mass
spectrometry require numerous cells for analysis. Therefore,
the major challenges of analyzing proteins at the single-cell
level are the exceedingly small copy number of individual
proteins and the lack of amplification methods. However, recent
advances in multiparameter flow cytometry, microfluidics, mass
spectrometry, mass cytometry, and other techniques have led to
new single cell proteomics studies that could be performed with
greater sensitivity and specificity.
Not only widely used in cell sorting, flow cytometry is also the
most established and user-friendly method for both qualitative
and quantitative multiparameter analysis of single cells. As
mentioned before, by using multiparameter flow cytometry,
scientists can simultaneously measure 10–15 key proteins in
signaling pathways in individual cells (De Rosa et al., 2001; Perez
and Nolan, 2002). In addition, in an immunological proof-of-
concept study, as many as 19 separate parameters including
17 fluorescent colors and 2 physical parameters were analyzed
(Perfetto et al., 2004). This strong ability has turned flow
cytometry into a powerful tool to semi-quantitatively analyze
pathways underlying many diseases (Irish et al., 2004; Sachs
et al., 2005). The main limitation is the spectral overlap due
to the broad spectral emission bands of organic fluorescent
dyes. Quantum dots mitigate but do not eliminate the problem.
Hence, complex correction algorithms are required for spectral
deconvolution. Moreover, commercial flow cytometers use cell
suspensions, which in turn allow individual interrogation of cells.
The sample preparation is still done manually and therefore,
requires a large numbers of cells (More than 10,000). This makes
it hard to analyze small samples, such as cells recovered from a
biopsy, tissue specimens or small volumes of blood.
To overcome these limitations, efforts have been made
to develop microfluidic-based miniaturized flow cytometers
which permit analysis of small numbers of cells (100–1000)
(Lindström and Andersson-Svahn, 2010). For example, Su and
colleagues developed a microscope-based label-free microfluidic
cytometer. It is capable of acquiring two dimensional light scatter
patterns from the smallest mature blood cells (platelets), cord
blood hematopoietic stem/progenitor cells (CD34 + cells), and
myeloid precursor cells (Su et al., 2011). Srivastava et al. (2009)
developed an integrated microfluidic device which retro-fitted
to commercial. The major advantage of this microfluidic device
is its ability to perform cell culture, stimulation and sample
preparation in combination with conventional fluorescence
imaging and microfluidic flow cytometry to monitor immune
response in macrophages. These microfluidic devices not only
drastically reduced the amount of sample and reagent required,
but also provided a means to perform two orthogonal modes of
measurements-imaging and cytometry, in one experiment.
Mass spectrometry (MS) is the most powerful tool for protein
analysis. However, MS’s use for analyzing proteins in single
cells is limited due to the lack of sensitivity to detect low
amounts of proteins. Fractionation of the cell lysate by capillary
electrophoresis (CE) prior to MS offers a good way to improve
sensitivity. Recently, a format for flow cytometry has been
developed that leverages the precision of mass spectrometry
which is termed mass cytometry. It can uniquely enable the
measurement of over 40 simultaneous cellular parameters on
single cells with the throughput capacity to survey millions of
cells from an individual sample (Mellors et al., 2010).
APPLICATION OF SINGLE CELL ANALYSIS
The exponential growth in studies applying single cell analysis is
explicitly tied to the acceptance of the technique by biologists.
Single cell analysis has influenced and impacted different
domains of science including cancer biology, neuroscience, and
immunology and so on. It is impossible to document each of
these developments. Therefore, a short overview of the fields of
applications that are typically addressed by single cell analysis is
presented in the research and application for cancer, brain and
stem cell, etc.
Application of Single Cell Analysis in
Cancer, Neuron Research
Intra-tumor heterogeneity has been widely reported in numerous
human cancer types. Tumors are frequently composed of
individual, molecularly distinct clones that differ in their
proliferation rates and metastatic potential, most critically,
in their sensitivities and responses to drug treatment. Those
cells that can cause distant metastases should possess unique
characteristics when compared to the remaining subpopulation.
Exome sequencing of single cells isolated from primary renal
carcinomas showed that only 31–37% of the genetic lesions
within a tumor are identical to the rest of the tumor cells
(Gerlinger et al., 2012; Xu et al., 2012). Therefore, analyzing the
occurrence, development and metastasis of these tumors at a
single cell level provides muchmore detailed information on how
a drug will respond to the tumor cells. It has been reported that
the PIK3CA mutations were detected in primary and metastatic
tumor tissues, but it is different periodically in single cells of
CTCs and DTCs indicated the drug efficacy (Deng et al., 2014).
Several important types of cancer cells have been discovered,
including primary tumor cells, metastatic tumor cells,
cancer stem cells (CSC), circulating tumor cells (CTC), and
disseminated tumor cells (DTC) (Zhang et al., 2016). CTC and
DTC play a vital role in cancer dissemination, self-renewal, and
distant metastases. They are being increasingly recognized for
their potential utility in disease monitoring and therapeutic
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targeting. Many cancer patients are diagnosed with early-stage
cancer with no clinical symptoms of metastasis but subsequently
succumb to metastatic relapse. One important reason is that
CTCs in the blood and DTCs have already reached a secondary
organ but have not yet grown to become clinical metastasis.
However, the CTCs are so rare among massive numbers of blood
cells, as few as one cell per 10 million white blood cells and 5
billion red blood cells, that the accurate identification of CTCs
turns out to be the most difficult step in the isolation process
(Deng et al., 2008). In recent years, a variety of enrichment and
detection techniques have been developed, making significant
progress in CTC detection. For example, the CellSearch R©
system (Janssen Diagnostics, NJ, USA) is the first and the
only technique that has been approved by the US FDA for the
detection, enrichment and quantification of CTCs in peripheral
whole blood samples (Riethdorf et al., 2007). This system
utilizes magnets with ferrofluid nanoparticles conjugated to
antibodies that target epithelial cell adhesion molecules, such
as EpCAM and CD45. EpCAM is the most commonly used
epithelial marker that is present on epithelial tumor cells while
CD45 is an immunocyte marker that is present on many
blood cells but absent in epithelial cells. Thus, the findings of
EpCAM-positive and CD45-negative cells indicate the presence
of CTCs. Another new immunomagnetic separation technology,
called MagSweeper (Illumina), involves dipping a rotating
magnetic rod with bound EpCAM antibodies in order to isolate
CTCs. Then moving the magnetic rod into a new buffer to
release the CTCs (Talasaz et al., 2009; Powell et al., 2012). The
MagSweeper can be used reliably to extract functional human
CTCs from the blood of mice inoculated with human tumor
xenografts, while retaining both their tumor-initiating and
metastasizing capacities (Ameri et al., 2010). This highlights the
most advantageous aspect of MagSweeper is that CTCs can be
completely isolated while preserving the integrity and viability of
these fragile cells.
In recent years, a large number of studies have been reported
using single cell analysis to analyze individual tumor cells isolated
from breast cancer (Navin et al., 2011; Deng et al., 2014; Wang
et al., 2014; Eirew et al., 2015), colon cancer (Zong et al., 2012;
Yu et al., 2014), pancreatic adenocarcinomas (Ruiz et al., 2011),
muscle-invasive bladder cancer (Li et al., 2012b), intestinal cancer
(Grün et al., 2015), lung adenocarcinoma cancer (Kim et al.,
2015), renal cell carcinoma (Gerlinger et al., 2012; Li et al.,
2012b), and acute myeloid leukemia (Ding et al., 2012; Hughes
et al., 2014; Paguirigan et al., 2015). For example, Navin and
colleagues investigated copy number variation in single tumor
cells usingDOPWGA followed byDNA sequencing to determine
cell population structure and tumor evolution patterns in a
single breast tumor (Navin et al., 2011). This study provided an
important breakthrough for research on tumor evolution and
offered a way to assess the genetic details of tumor structure.
Hou and colleagues applied MDA based single cell sequencing
technology for the first time to analyze primary thrombocytosis
disease (essential immature, ET) in patients at single bone
marrow cell level (Hou et al., 2012). Thus, understanding
tumor heterogeneity via single cell analysis is considered
the biggest challenge in cancer research and if elucidated
would enhance our ability to determine the best treatment
options.
It is no exaggeration to say that the brain is the most
complex structure in the human body. There are more
than 100 billion neurons in the human brain. Each of
them can make approximately 10,000 direct connections with
others, totaling some 100 trillion nerve connections. This
makes the brain a complicated network (Herculano-Houzel,
2009). The brain is divided into several regions. Each region
consist of various morphologically and/or neurochemically
distinct neurons surrounded by various types of glial cells
(oligodendrocytes, microglia, and astrocytes). Additionally,
distinct regions in the brain, such as areas of the cerebral
cortex, hippocampus have specific functions. The cerebral
cortex is responsible for many "higher-order" functions like
language and information processing while the hippocampus is
involved in spatial learning and memory. Increasing evidence
shows that each brain region contains different types of
neurons according to their location, neurotransmitter identity,
connectivity, electrophysiological properties, and molecular
markers. Changes of genomic content and epigenetic profiling of
specific neuronal or glia subtypes are involved in the pathogenesis
of neuropsychiatric diseases, such as Parkinson’s and Alzheimer’s
diseases and autism spectrum disorders(Citri et al., 2012).
Hence there is no doubt that single cell isolation and
analysis have made increasingly significant contributions to
our understanding of the role that somatic genome variations
play in neuronal diversity and behaviors. For example, MACS
based technique has been successfully applied to isolating
immature neuronal cells from a large number of embryonic
zebrafish; the antibody of PSA-NCAM conjugated microbeads
were used within a semi-automated dissociation process. (Welzel
et al., 2015). Moreover, the MACS was also used for the
isolation of embryonic spinal oligodendroglial progenitor cell
populations from the rat embryonic spinal cord. By using
superparamagnetic MicroBeads combined with A2B5 antibodies
(a specific oligodendroglial development marker) and the Mini-
MACS separator column, the oligodendroglial cells were isolated
with a cell purity of 58–61% in comparison to 6–12% in an
unseparated population (Cizkova et al., 2009).
Moreover, basolateral amygdala (BLA) neurons are used to
activate distinct populations of the lateral central nucleus of
the amygdala (CeL) neurons to either promote fear or reduce
anxiety. Namburi and colleagues identified two populations
of neurons in the basolateral amygdala neurons that undergo
opposing synaptic changes following fear (negative emotion)
or reward (positive emotion) conditioning. By using RNA-
seq they identified few differentially expressed candidate genes
between these two population neurons that may mediate the
effects (Namburi et al., 2015). Usoskin and colleagues used
comprehensive transcriptome analysis of 622 single mouse
neurons from sensory system and discovered 11 fundamentally
distinct types of sensory neurons. Interestingly, each neuron
is associated with a different type of sensation (Usoskin et al.,
2015). Even cells that appear to be morphologically similar may
show marked differences in expression patterns. In neuroscience
research, electrophysiological analysis combined with molecular
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biology within the same cell will provide convincing results for
us to better understand of how changes at the molecular level are
manifested in functional properties (Eberwine et al., 1992).
Applications of Single Cell Analysis in Stem
Cell Research
Stem cells are undifferentiated cells that are characterized as
both being capable of self-renewal and having the potential to
differentiate into specialized types of cells. How stem cells balance
their self-renewal capacity and their ability to differentiate are
central questions in stem cell research. Stem cells can be generally
classified into pluripotent stem cells, which can give rise to cells of
all three germ layers (the ectoderm, mesoderm, and endoderm)
or tissue-specific stem cells (also referred to as somatic or adult
stem cells), which play essential roles in the development of
embryonic tissues and the homeostasis of adult tissues. Both of
these two types of stem cells are intermingled with a variety
of differentiated and intermediate cell types in the embryonic
or adult tissues, forming heterogeneous populations. Therefore,
isolation, analysis, and development of specific therapies that
target stem cells give cancer patients hope for improvement in
terms of survival and quality of life, (Li et al., 2008; Sharma et al.,
2010).
Cancer stem cells (CSCs) are hypothesized to persist in tumors
as a distinct population and cause relapses and metastases by
forming new tumors. CSC are intrinsically more refractory to the
effects of a variety of anticancer drugs possibly via enhanced drug
eﬄux (Trumpp and Wiestler, 2008). These cells are especially
resistant to therapeutic drugs. Due to the limited number of CSCs
in cancer tissues, isolation and analysis CSCs are still a hard work.
Single cell sequencing provides powerful tools for identifying
these cells providing new insight into complex intra-tumoral
heterogeneity. For example, Patel et al. (2014) used single-cell
RNA sequencing to profile 672 single cells from five primary.
Each tumor showed high intra-tumoral cell heterogeneity in
many aspects, including copy number variations as well as
cell cycle, immune response and hypoxia. By examining a set
of “stemness” genes, they identified continuous, rather than
discrete, stemness-related expression states among the individual
cells of all five tumors, reflecting the complex stem cell states
within a primary tumor. It has been suggested that CSCs are
more resistant to chemo—and radiotherapy than other cells in
a tumor. This could be one explanation to why most tumors
relapse after therapy. Thus, understanding how cancer stem cells
resist medical therapy could lead to the development of new,
more efficient cancer treatments. Although the existence of these
CSCs is still controversial in many cancer types, there is no doubt
that CSCs have the potential to provide a foundation for new
innovative treatment targeting the roots of cancer.
The neural stem cells (NSCs) in the subventricular zone (SVZ)
and the subgranular zone (SGZ) of the dentate gyrus continually
divide and differentiate into mature neurons and glia in the
adult rodent brain (Aimone et al., 2014). Although it has been
documented that endogenous NSCs can be activated to produce
multiple types of progeny to contribute to brain repair after brain
injury, people do not know how distinct pools of NSCs may
react to brain injury and which molecules trigger injury-induced
activation of NSCs. Single-cell sequencing reveals a population
of dormant neural stem cells in the SVZ that become activated
upon brain injury by down regulation of glycolytic metabolism
and a concomitant up regulation of lineage-specific transcription
factors and protein synthesis (Llorens-Bobadilla et al., 2015).
Increasing evidence shows that multiple molecularly distinct
groups of stem cells that respond differently to physiological
stimuli coexist in the tissues. Understanding and implementing
this molecular diversity will be critical in harnessing the potential
of disease treatment.
CONCLUSION AND OUTLOOK
The biological relevance of cell to cell variations and the high
potential of single cell analysis in both basic research and
clinical diagnostics have drawn the attention of the scientific
community. Single cell gene expression analysis can be used
for tumor cell identification; single cell DNA mutation analysis
can be used for tumor cell monitoring and clinical decision
making (Powell et al., 2012; Deng et al., 2014). Understanding
cellular heterogeneity has been a major thrust of technological
development over the past decade, resulting in an increasingly
powerful suite of instrumentation, protocols, and methods for
analyzing single cells at the DNA sequence, RNA expression and
protein abundance levels (Kalisky et al., 2011; Wu and Singh,
2012). As remarkable examples, technical developments, and
appropriate clinical solutions based on single cell analyses of
CTCs and CSCs showed the promise to uncover personalized
medicine to fight against cancer.
Although much progress has been made during the recent
years in single cell gene analysis, live single cell isolation and
molecular analyses are more favorable for global profiling of
RNA expression and DNA mutation (Powell et al., 2012). We
are still only beginning to face the measurement challenges of
cellular heterogeneity. There is still more room for improvement
in enabling new modes of analysis and improving the sensitivity,
precision, speed and throughput (Lecault et al., 2012).
For single cell genomic and gene expression analyses,
the greatest obstacle for direct detection of diverse genomic,
transcriptomic, and epigenetic events is whether there is a
sufficient amount of DNA or RNA. On the one hand, purification
of high-quality nucleotides from a single sample plays a pivotal
role for the following studies. A problem that is commonly faced
is tube absorption which causes loss of sample materials. Low
absorption material containers instead of ordinary tubes and
single tube reaction analysis are recommended to reduce the
loss of DNA and RNA, single cell direct PCR/RT-PCR without
nucleotide isolation are also often used. Another problem is the
low replication efficiency of secondary structure DNA sequences.
Methods for current single cell sequencing still have relatively
high technical noise. It is acceptable when studying highly
expressed genes, but the biological variations of genes that are
expressed at low levels may be masked. Thus, the efficiency of
reverse transcription and PCR amplification should be urgently
improved. On the other hand, this problem could be overcome
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by the third-generation sequencing platforms, which are based
on sequencing single molecules and real-time signal monitoring
(Schadt et al., 2010; Liu et al., 2012). Within third-generation
sequencing technology, no amplification is required and it
also overcomes the issue of PCR amplification bias. However,
the detection sensitivity, accuracy of sequencing reads, sample
handling, recovery, and sequence assembly still need to be further
improved.
Protein analysis is far more challenging than nucleic acid
analysis. Undoubtedly, the complexity of the proteome, lack of
amplification methods and highly specific high-affinity probes
make protein analysis technically demanding. Because the cell
contents are highly diluted after lysis, high affinity probes (not
only monoclonal antibodies), and highly sensitive detection
methods are needed to detect low abundance proteins and post-
translational modifications.
To summarize, single cell analysis now stands poised to
illuminate this new layer of biological complexity under normal
development and disease conditions. Considering the rapid
progress in either the development of single cell isolation or
analysis technology, many of the problems mentioned above will
be solved in the near future. Nevertheless, further developments
and interdisciplinary co-operative work between technologists,
scientists, and clinicians will be necessary. In the distant future,
we expect that the single cell techniques will become a powerful
tool to unravel longstanding questions in both biological research
and clinical diagnostics.
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